|
|
When L.D.L. levels dropped, plaque growth slowed. That means, concludes Dr. Nissen – author of the study, that the benefit of lowering L.D.L. is the same whether H.D.L. levels are high or low.
H.D.L. is also known as the good cholesterol. For years, according to the good cholesterol hypothesis, biochemists believe that H.D.L. acts to remove the bad cholesterol (L.D.L.) from the blood stream. The hypothesis was based on the results of the Framingham Heart Study and similar studies. In the Framingham Heart Study, thousands of patients were monitored for development of heart disease. The study found that when two persons with the same levels of the bad cholesterol L.D.L. but different levels of the good cholesterol, H.D.L, the one with more H.D.L. was less likely to have heart disease.
But now, with the emergence of results from recent studies like the one mentioned above, scientists start to question the true benefit of H.D.L. On the other hand, these new studies seem to suggest that the lower the L.D.L level, the more protective benefits patients will experience from heart disease. Until further data and new treatment guideline become available, many physicians think that treating L.D.L. with cholesterol-lowering statins, even when H.D.L. is high, is within reasonable practice.
|
|
|
|
Copyright © 2004 All materials contained herein are intellectual properties of the Asian Society of Healthcare Information. Unauthorized copy or redistribution for commercial purposes is prohibited and will be penalized under law. Permission for academic uses may be obtained by contacting ASHInfo at generalinfo@ashinfo.net
Disclaimer: The information provided herein is not intended as a substitute for your healthcare experts’ judgment, skill, and knowledge. Drug information may not cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. All materials may be subject to time sensitivity.
|
|